The User Acceptance phase of interactive response technology is a critical time to ensure the system requirements were interpreted correctly for a clinical trial protocol. In this webinar, the featured speaker will look at the different levers a clinical trial organization can pull to reduce the amount of time spent in User Acceptance Testing (UAT) while still demonstrating sound oversight for a complex clinical trial design.
Register for this webinar to learn the various techniques top pharma use to complete a successful, efficient User Acceptance Testing while maintaining quality and timeline key performance indicators and trial oversight. The speakers will explore several lessons learned from their experience of creating and consulting on bespoke UAT approaches.
Antoinette Walsh, CT PA, Director of Technical Solutions, Almac Clinical Technologies
Antoinette Walsh is an established software delivery leader with extensive experience working in regulated industries such as healthcare and finance. For over the past 13 years, she has developed and implemented software testing and UAT strategies in the IRT space at Almac Clinical Technologies, first as a Software Tester and currently as a Director of Technical Solutions.
Antoinette is an Excel whiz and champion of leveraging automation and reporting to reduce manual effort, re-work and waste not only in UAT, but in the business processes and systems she is responsible for.
Who Should Attend?
- Pharmaceutical, CRO
- Study Leads/Managers
- Vendor Managers
- IRT Experts
- Medication/Supply Managers
- System Validation Personnel
What You Will Learn
Attendees will be introduced to:
- Effective tactics for structuring data and User Acceptance Testing (UAT) scripts to gain efficiencies
- How automation tools can help reduce manual effort
- Vendor processes and services and how to leverage them to define strategy and focus tests on high risk cases
For over 25 years Almac Clinical Technologies group has been leading the Interactive Response Technology industry with over 700 clients and 4000 trials, bringing together the most innovative technology and our unparalleled expertise to empower biopharmaceutical industry and help bring new therapies to patients.